Fossacesia, Italy

Daniela Corda

This inventor holds 1 USPTO granted patent. Top assignee: I.r.b. Istituto Di Ricerche Biotechnologiche S.r.l.. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniela Corda. Retrieved from https://idiyas.com/inventor/daniela-corda-dy2voabw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Daniela Corda: Innovator in Biotechnological Research

Introduction

Daniela Corda is a prominent inventor based in Fossacesia, Italy. She has made significant contributions to the field of biotechnological research, particularly in the area of glycerophosphoinositol derivatives. Her work focuses on the modulation of cytosolic A2 phospholipase, which has important implications for pharmacology.

Latest Patents

Corda holds a patent for "Glycerophosphoinositol derivatives as modulators of cytosolic A2 phospholipase." This patent includes O-substituted glycero-phosphoinositol derivatives, their analogues, and their salts. The patent details the synthesis of these compounds and their pharmacological effects as modulators of the activation or over-stimulation of cPLA2.

Career Highlights

Daniela Corda is associated with I.R.B. Istituto di Ricerche Biotechnologiche S.r.l., where she continues her innovative research. Her work has garnered attention for its potential applications in medical science and pharmacology.

Collaborations

Corda collaborates with notable colleagues, including Roberto Dal Toso and Giovanna Bonvento. Their combined expertise enhances the research output and innovation at their institution.

Conclusion

Daniela Corda is a key figure in biotechnological innovation, with her patent reflecting her commitment to advancing scientific knowledge. Her contributions are paving the way for future developments in pharmacological applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…